Literature DB >> 30036072

HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.

Jillian Pintye1,2, Kristin M Beima-Sofie1, Pamela A Makabong'O3, Anne Njoroge1, Susan Brown Trinidad4, Renee A Heffron1,5, Jared M Baeten1,5,6, Connie Celum1,5,6, Daniel Matemo7, John Kinuthia1,7, Maureen C Kelley8, Grace C John-Stewart1,5,6.   

Abstract

To optimize scale-up of pre-exposure prophylaxis (PrEP) for pregnant women at risk of HIV in high HIV burden settings, implementation strategies must be developed that account for perceptions of PrEP in this unique population. Semistructured focus group discussions were conducted with 68 HIV-uninfected Kenyan pregnant and postpartum women without prior PrEP knowledge or experience. A qualitative descriptive analysis was performed, using a constant comparison approach, to identify key themes related to the values and rationale impacting potential PrEP use in pregnancy. Median age was 19.5 years and participants were either pregnant or had 1-2 children. Almost all (96%) were married or had a steady partner. Women felt pregnancy was a time of high HIV risk because they desired sex less frequently, which may lead their partners to have outside partnerships. This made PrEP an attractive HIV prevention option for themselves and their infants. Although women believed male partner behaviors influenced their HIV risk, many women perceived that male partners would react negatively, including becoming physically violent, if they discovered that women used PrEP. Clinicians were identified as potential facilitators of PrEP use who could explain PrEP to male partners on behalf of pregnant women. Women said that community-level stigma against HIV and potential for conflating PrEP with antiretroviral therapy (ART) would necessitate that PrEP use be discreet. Our results indicate the importance of addressing risk perception of women, concerns of male partners, HIV stigma, and benefits of PrEP for HIV prevention as programs are developed for pregnant women.

Entities:  

Keywords:  Africa; PrEP; obstetrics/gynecology; prevention of mother to child transmission/vertical transmission; prevention of sexual transmission; qualitative data; women

Mesh:

Substances:

Year:  2018        PMID: 30036072      PMCID: PMC6300042          DOI: 10.1089/apc.2018.0058

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  22 in total

1.  "I Did Not Want to Give Birth to a Child Who has HIV": Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples.

Authors:  Jillian Pintye; Kristin M Beima-Sofie; Grace Kimemia; Kenneth Ngure; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Josephine Odoyo; Nelly Mugo; Elizabeth A Bukusi; Maureen C Kelley; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

2.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

3.  Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.

Authors:  Jennifer J Carroll; Renee Heffron; Nelly Mugo; Kenneth Ngure; Patrick Ndase; Stephen Asiimwe; Connie Celum; Jared M Baeten
Journal:  Sex Transm Dis       Date:  2016-08       Impact factor: 2.830

4.  The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.

Authors:  Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

Review 5.  Understanding the complexity of the immune system during pregnancy.

Authors:  Karen Racicot; Ja-Young Kwon; Paulomi Aldo; Michelle Silasi; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2014-07-04       Impact factor: 3.886

6.  Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.

Authors:  Renee Heffron; Kerry Thomson; Connie Celum; Jessica Haberer; Kenneth Ngure; Nelly Mugo; Elizabeth Bukusi; Elly Katabira; Josephine Odoyo; Nulu Bulya; Stephen Asiimwe; Edna Tindimwebwa; Jared M Baeten
Journal:  AIDS Behav       Date:  2018-06

7.  Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.

Authors:  Alejandra Cabral; Jared M Baeten; Kenneth Ngure; Jennifer Velloza; Josephine Odoyo; Jessica E Haberer; Connie Celum; Timothy Muwonge; Stephen Asiimwe; Renee Heffron
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

8.  Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation.

Authors:  Thu-Ha Dinh; Kevin P Delaney; Ameena Goga; Debra Jackson; Carl Lombard; Selamawit Woldesenbet; Mary Mogashoa; Yogan Pillay; Nathan Shaffer
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

9.  Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.

Authors:  Sarah T Roberts; Jessica Haberer; Connie Celum; Nelly Mugo; Norma C Ware; Craig R Cohen; Jordan W Tappero; James Kiarie; Allan Ronald; Andrew Mujugira; Elioda Tumwesigye; Edwin Were; Elizabeth Irungu; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

10.  Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.

Authors:  Natasha Mack; Jacob Odhiambo; Christina M Wong; Kawango Agot
Journal:  BMC Health Serv Res       Date:  2014-05-21       Impact factor: 2.655

View more
  25 in total

1.  Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal and child health and family planning clinics.

Authors:  Jillian Pintye; Alison L Drake; Emily Begnel; John Kinuthia; Felix Abuna; Harison Lagat; Julia Dettinger; Anjuli D Wagner; Harsha Thirumurthy; Kenneth Mugwanya; Jared M Baeten; Grace John-Stewart
Journal:  AIDS       Date:  2019-07-01       Impact factor: 4.177

2.  Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa.

Authors:  Laia Vazquez; Anthony P Moll; Alexa Kacin; Ntombi Euginia Ndlovu; Sheela V Shenoi
Journal:  AIDS Patient Care STDS       Date:  2019-05       Impact factor: 5.078

3.  Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.

Authors:  Zoe Rogers; Jillian Pintye; John Kinuthia; Gabrielle O'Malley; Felix Abuna; Jaclyn Escudero; Melissa Mugambi; Mercy Awuor; Annabell Dollah; Julia C Dettinger; Pamela Kohler; Grace John-Stewart; Kristin Beima-Sofie
Journal:  AIDS Care       Date:  2021-09-20

4.  Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya.

Authors:  Ingrid T Katz; Kenneth Ngure; Kevin Kamolloh; Vallery Ogello; Moses Okombo; Nicholas B Thuo; Esther Owino; Lindsey E Garrison; Yeonsoo S Lee; Maria F Nardell; Chiemelie Anyacheblu; Elizabeth Bukusi; Nelly Mugo; Jared M Baeten; Jessica E Haberer
Journal:  AIDS Behav       Date:  2022-08-05

5.  High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.

Authors:  Joseph Sila; Anna M Larsen; John Kinuthia; George Owiti; Felix Abuna; Pamela K Kohler; Grace John-Stewart; Jillian Pintye
Journal:  AIDS Patient Care STDS       Date:  2020-08       Impact factor: 5.078

6.  High pre-exposure prophylaxis awareness and willingness to pay for pre-exposure prophylaxis among young adults in Western Kenya: results from a population-based survey.

Authors:  Emily R Begnel; Jaclyn Escudero; Melissa Mugambi; Kenneth Mugwanya; John Kinuthia; Kristin Beima-Sofie; Julia C Dettinger; Jared M Baeten; Grace John-Stewart; Jillian Pintye
Journal:  Int J STD AIDS       Date:  2020-03-24       Impact factor: 1.359

7.  Influences on Early Discontinuation and Persistence of Daily Oral PrEP Use Among Kenyan Adolescent Girls and Young Women: A Qualitative Evaluation From a PrEP Implementation Program.

Authors:  Jillian Pintye; Gabrielle O'Malley; John Kinuthia; Felix Abuna; Jaclyn N Escudero; Melissa Mugambi; Mercy Awuor; Annabell Dollah; Julia C Dettinger; Pamela Kohler; Grace John-Stewart; Kristin Beima-Sofie
Journal:  J Acquir Immune Defic Syndr       Date:  2021-04-01       Impact factor: 3.771

8.  Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique.

Authors:  Daniel E Sack; Caroline De Schacht; Paula Paulo; Erin Graves; Almiro M Emílio; Ariano Matino; Carlota L Fonseca; Arifo U Aboobacar; Sara Van Rompaey; Carolyn M Audet
Journal:  Glob Health Action       Date:  2021-01-01       Impact factor: 2.640

9.  Perceived Social Influences on Women's Decisions to use Medications not Studied in Pregnancy. A Qualitative Ethical Analysis of Preexposure Prophylaxis Implementation Research in Kenya.

Authors:  Kenneth Ngure; Susan B Trinidad; Kristin Beima-Sofie; John Kinuthia; Daniel Matemo; Grace Kimemia; Anne Njoroge; Lillian Achiro; Jillian Pintye; Nelly R Mugo; Elizabeth A Bukusi; Jared M Baeten; Renee Heffron; Grace John-Stewart; Maureen C Kelley
Journal:  J Empir Res Hum Res Ethics       Date:  2021-06-16       Impact factor: 1.742

10.  Views among Malawian women about joining HIV prevention clinical trials when pregnant.

Authors:  Kristen Sullivan; Tiwonge Mtande; Elana Jaffe; Nora Rosenberg; Chifundo Zimba; Irving Hoffman; Maggie Little; Ruth Faden; Anne Drapkin Lyerly
Journal:  AIDS Res Ther       Date:  2020-05-27       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.